Transcription of HPLC method development for the simultaneous analysis of ...
{{id}} {{{paragraph}}}
*Correspondence: S. Alt n z. Hacettepe University, Faculty of Pharmacy, Department of Analytical Chemistry. 06100 - Ankara- TURKEY. E-mail: Journal of Pharmaceutical Sciencesvol. 46, n. 4, , 2010 HPLC method development for the simultaneous analysis of amlodipine and valsartan in combined dosage forms and in vitro dissolution studiesMustafa elebier1, Mustafa Sinan Kaynak2,3, Sacide Alt n z1,*, Selma Sahin21 Department of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey, 2 Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey, 3 Department of Pharmaceutical Technology, Faculty of Pharmacy, In n University.
HPLC method development for the simultaneous analysis of amlodipine and valsartan 763 Array Detector (Waters, USA). A C18 column (Waters Spherisorp (PSS832514) ODS 2, 10 µm, 200 x 4.6 mm;
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
14227/DT190412P36 Development and, Dissolution, Development and Validation, Dissolution method, Discriminatory Dissolution Method Development and, Of dissolution, Dissolution method development, Method Validation in Pharmaceutical Analysis, Development, Validation, VALIDATION OF ANALYTICAL METHODS, GUIDELINES ON VALIDATION APPENDIX 4, PRODUCT DEVELOPMENT GUIDE P RE-FORMULATION